39 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07123 | DEE | GLLDLLELLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 6.05 ± 2.76 µM |
| dbacp07126 | EEE | GLLELLELLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 10.55 ± 3.46 µM |
| dbacp07129 | HEE | GLLHLLELLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 4.95 ± 0.49 µM |
| dbacp07132 | KEE | GLLKLLELLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.05 ± 0.21 µM |
| dbacp07135 | DHE | GLLDLLHLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.80 ± 0.14 µM |
| dbacp07138 | EHE | GLLELLHLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.55 ± 0.07 µM |
| dbacp07141 | HHE | GLLHLLHLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 10.75 ± 0.78 µM |
| dbacp07144 | KHE | GLLKLLHLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.92 ± 0.17 µM |
| dbacp07147 | DKE | GLLDLLKLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.57 ± 0.33 µM |
| dbacp07150 | EKE | GLLELLKLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.30 ± 0.14 µM |
| dbacp07153 | HKE | GLLHLLKLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.90 ± 0.42 µM |
| dbacp07156 | KKE | GLLKLLKLLLEAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.70 ± 0 µM |
| dbacp07159 | DEH | GLLDLLELLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 3.60 ± 0.42 µM |
| dbacp07162 | EEH | GLLELLELLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 3.60 ± 0.85 µM |
| dbacp07165 | HEH | GLLHLLELLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 10.95 ± 1.06 µM |
| dbacp07168 | KEH | GLLKLLELLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.35 ± 0.07 µM |
| dbacp07171 | DHH | GLLDLLHLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 11.90 ± 0.14 µM |
| dbacp07174 | EHH | GLLELLHLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 16.05 ± 3.18 µM |
| dbacp07177 | HHH | GLLHLLHLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 9.50 ± 0.99 µM |
| dbacp07180 | KHH | GLLKLLHLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 4.45 ± 0.49 µM |
| dbacp07183 | DKH | GLLDLLKLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.80 ± 0.28 µM |
| dbacp07186 | EKH | GLLELLKLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.18 ± 0.31 µM |
| dbacp07189 | HKH | GLLHLLKLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 3.10 ± 0.57 µM |
| dbacp07192 | KKH | GLLKLLKLLLHAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.20 ± 0.42 µM |
| dbacp07195 | DEK | GLLDLLELLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 0.70 ± 0.07 µM |
| dbacp07198 | EEK | GLLELLELLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.08 ± 0.18 µM |
| dbacp07201 | HEK | GLLHLLELLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 3.45 ± 2.19 µM |
| dbacp07204 | KEK | GLLKLLELLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.35 ± 0.07 µM |
| dbacp07207 | DHK | GLLDLLHLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.02 ± 0.12 µM |
| dbacp07210 | EHK | GLLELLHLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 0.71 ± 0.13 µM |
| dbacp07213 | HHK | GLLHLLHLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.75 ± 0.21 µM |
| dbacp07216 | KHK | GLLKLLHLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.40 ± 0.14 µM |
| dbacp07219 | DKK | GLLDLLKLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.20 ± 0.14 µM |
| dbacp07222 | EKK | GLLELLKLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.19 ± 0.40 µM |
| dbacp07225 | HKK | GLLHLLKLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 2.60 ± 0.42 µM |
| dbacp07228 | KKK | GLLKLLKLLLKAAGW | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 1.35 ± 0.40 µM |
| dbacp07231 | d-DHK | GlldllhlllkaaGw | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 0.23 ± 0.04 µM |
| dbacp07234 | d-DEK | GlldllelllkaaGw | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 0.36 ± 0 µM |
| dbacp07237 | d-EEK | GllellelllkaaGw | Synthetic | Selective membrane perforation prevents resistance. | MTT assay | HMLER-shEcad | Breast Cancer | IC50 = 0.29 ± 0.01 µM |